Biologics Developers Can Use Industry Standards, FDA Says

January 10, 2018

Biologics sponsors are encouraged to follow established, voluntary standards when developing new products, the Food and Drug Administration (FDA) said in new draft guidance it issued on Dec. 19 (82 Fed. Reg. 60,204).

Related Stories